Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

3042-84-0

Bromopyrazone

3042-84-0
51249-05-9

Buminafos

51249-05-9
72962-43-7

Brassinolide

72962-43-7
67-52-7

Barbituric acid, Reagentplus

67-52-7
78982-84-0

Bromchlorbuterol hydrochloride

78982-84-0
22601-59-8

Bacitracin A

22601-59-8
66917-44-0

Betamethasone Dipropionate EPImpurity

66917-44-0
66917-44-0

Betamethasone Dipropionate EPImpurity J

66917-44-0
4419-39-0

Beclometasone

4419-39-0
7585-39-9

Cyclodextrin-beta

7585-39-9
289472-78-2

(R)-Hydroxy Des(boric Acid) Bortezomib

289472-78-2
886979-78-8

(S,R)-Hydroperoxy Des(boric Acid) Bortezomib

886979-78-8
58786-99-5

Butorphanol Tartrate

58786-99-5
58-08-2

Caffein

58-08-2
404-86-4

Capsaicin

404-86-4
298-46-4

Carbamazepine

298-46-4
5786-21-0

Clozapine

5786-21-0
303-98-0

COEnzyme Q10

303-98-0
882-09-7

Clofibrinic acid

882-09-7
56-75-7

Chloramphenicol

56-75-7